Undergraduate Research Fellow @ (June 2004 - June 2006)
Austin Speier Education
Harvard University
A.B. (Neurobiology)
2002-2006
Austin Speier Skills
Lifesciences
Biotechnology
Medical Devices
FDA
Clinical Trials
Pharmaceutical Industry
Regulatory Submissions
Regulatory Affairs
Commercialization
Start-ups
Drug Development
Strategy
Clinical Research
Oncology
Technology Transfer
Quality System
Biopharmaceuticals
Regulatory Requirements
Neuroscience
Life Sciences
Strategic Consulting
Clinical Affairs
Biostatistics
R&D
Start-up Ventures
Start-up Consulting
Startup Development
Product Development
Business Development
Venture Capital
Capital Raising
Due Diligence
Cardiovascular Devices
Cardiovascular
Neurology
Neurostimulation
Orthopedic
Translational Medicine
Cosmetic Medicine
Gastroenterology
Urology
Stem Cell Technology
Mobile Health
Health 2.0
Healthcare Industry
Consumer Healthcare
Personalized Medicine
Medical Diagnostics
Biomarkers
Go to Market Strategy
Microsoft Office
Contract Negotiations
Matlab
Fundraising
Teaching
Business Strategy
Lean Startups
Fda Submissions
Fluent in German
Managing Startups
Public Speaking
Product and Marketing Strategy
Clinical Study Design
Business Operations
Competitive Intelligence
Product Strategy
Statistics
Start Ups
Start Up Ventures
Competitive Differentiation
Start Up Consulting
Regulatory Compliance
Market Research
u.s. Food and Drug Administration Fda
u.s. Food and Drug Administration
Austin Speier Summary
Austin Speier, based in New York, United States, is currently a Chief Strategy Officer at Click Therapeutics, Inc.. Austin Speier brings experience from previous roles at Precision For Medicine, Becker & Associates Consulting, Inc. and Brigham and Women's Hospital. Austin Speier holds a 2002 - 2006 A.B. in Neurobiology @ Harvard University. With a robust skill set that includes Lifesciences, Biotechnology, Medical Devices, FDA, Clinical Trials and more. Austin Speier has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Austin Speier?
Find contact details for 700 million professionals.